二尖瓣的原发性心脏血管内皮瘤

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Egyptian Heart Journal Pub Date : 2018-09-01 DOI:10.1016/j.ehj.2018.06.002

Sherif Arafa , Mohammad Sanad

{"title":"二尖瓣的原发性心脏血管内皮瘤","authors":"Sherif Arafa , Mohammad Sanad","doi":"10.1016/j.ehj.2018.06.002","DOIUrl":null,"url":null,"abstract":"<div><p>Primary cardiac hemangioendothelioma is a very rare tumor. Up to now, <20 cases have been reported worldwide; involvement of mitral valve by the tumor is extremely rare. In this report, a case of hemangioendothelioma arose from the mitral valve and was successfully resected, and after few months the tumor recurred and infiltrated the heart.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 3","pages":"Pages 229-232"},"PeriodicalIF":1.4000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2018.06.002","citationCount":"3","resultStr":"{\"title\":\"Primary cardiac hemangioendothelioma of the mitral valve\",\"authors\":\"Sherif Arafa , Mohammad Sanad\",\"doi\":\"10.1016/j.ehj.2018.06.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Primary cardiac hemangioendothelioma is a very rare tumor. Up to now, <20 cases have been reported worldwide; involvement of mitral valve by the tumor is extremely rare. In this report, a case of hemangioendothelioma arose from the mitral valve and was successfully resected, and after few months the tumor recurred and infiltrated the heart.</p></div>\",\"PeriodicalId\":44962,\"journal\":{\"name\":\"Egyptian Heart Journal\",\"volume\":\"70 3\",\"pages\":\"Pages 229-232\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2018-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ehj.2018.06.002\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Heart Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1110260818301108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1110260818301108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 3

摘要

摘要原发性心脏血管内皮瘤是一种非常罕见的肿瘤。截至目前，全球共报告20例;肿瘤累及二尖瓣极为罕见。在本报告中，一例血管内皮瘤起源于二尖瓣并被成功切除，几个月后肿瘤复发并浸润心脏。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Primary cardiac hemangioendothelioma of the mitral valve

查看原文本刊更多论文

Primary cardiac hemangioendothelioma of the mitral valve

Primary cardiac hemangioendothelioma is a very rare tumor. Up to now, <20 cases have been reported worldwide; involvement of mitral valve by the tumor is extremely rare. In this report, a case of hemangioendothelioma arose from the mitral valve and was successfully resected, and after few months the tumor recurred and infiltrated the heart.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Egyptian Heart Journal CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

2.10

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： The Egyptian Heart Journal is the official journal of the Egyptian Society of Cardiology. It is an international journal that publishes peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies and translational investigations. The journal publishes research, review articles, case reports and commentary articles, as well as editorials interpreting and commenting on the research presented. In addition, it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including educational issues.